23:
256:
266:
276:
271:
286:
291:
246:
281:
251:
261:
75:
135:
296:
87:
301:
159:
366:
19:
342:
323:
222:
139:
57:
212:
185:
202:
163:
361:
236:
27:
241:
33:
Many conditions of or affecting the human integumentary system have associated abnormalities of the
371:
189:
61:
41:
Dental abnormalities associated with conditions of or affecting the human integumentary system
131:
8:
196:
170:
114:
65:
22:
and may never be able to satisfy particular standards for completeness. You can help by
97:
79:
338:
319:
119:
107:
83:
355:
154:
147:
143:
257:
List of cutaneous conditions caused by problems with junctional proteins
267:
List of histologic stains that aid in diagnosis of cutaneous conditions
126:
277:
List of inclusion bodies that aid in diagnosis of cutaneous conditions
272:
List of immunofluorescence findings for autoimmune bullous conditions
287:
List of radiographic findings associated with cutaneous conditions
175:
292:
List of specialized glands within the human integumentary system
247:
List of cutaneous conditions associated with internal malignancy
209:
Grey–green discoloration of the mid-portion of permanent teeth
34:
282:
List of keratins expressed in the human integumentary system
252:
List of cutaneous conditions caused by mutations in keratins
182:
Loss of deciduous and permanent teeth by late childhood
335:
76:
Herlitz variant of junctional epidermolysis bullosa
332:
313:
353:
219:Brown discoloration of gingival third of teeth
262:List of genes mutated in cutaneous conditions
333:James, William D.; et al. (2006).
314:Bolognia, Jean L.; et al. (2007).
354:
297:List of target antigens in pemphigoid
302:List of target antigens in pemphigus
160:Congenital erythropoietic porphyria
13:
14:
383:
223:Tetracycline-induced pigmentation
140:Hypohidrotic ectodermal dysplasia
58:Hypohidrotic ectodermal dysplasia
213:Minocycline-induced pigmentation
136:Schöpf–Schulz–Passarge syndrome
203:Pachyonychia congenita type II
164:Hepatoerythropoietic porphyria
1:
307:
88:Tricho–dento–osseous syndrome
237:List of cutaneous conditions
7:
230:
10:
388:
94:Retention of primary teeth
17:
367:Dermatology-related lists
242:List of contact allergens
186:Papillon–Lefèvre syndrome
62:Incontinentia pigmenti
337:. Saunders Elsevier.
362:Cutaneous conditions
318:. St. Louis: Mosby.
132:Hypomelanosis of Ito
24:adding missing items
197:Premature dentition
171:Eroded tooth enamel
115:Supernumerary teeth
66:Congenital syphilis
42:
190:Haim–Munk syndrome
98:Hyper-IgE syndrome
80:Tuberous sclerosis
40:
228:
227:
104:Non-erupted teeth
379:
348:
329:
120:Gardner syndrome
108:Gardner syndrome
43:
39:
28:reliable sources
387:
386:
382:
381:
380:
378:
377:
376:
372:Tooth pathology
352:
351:
345:
326:
310:
233:
188:
162:
146:
142:
138:
134:
86:
84:Gorlin syndrome
82:
78:
64:
60:
31:
12:
11:
5:
385:
375:
374:
369:
364:
350:
349:
343:
330:
324:
309:
306:
305:
304:
299:
294:
289:
284:
279:
274:
269:
264:
259:
254:
249:
244:
239:
232:
229:
226:
225:
220:
216:
215:
210:
206:
205:
200:
193:
192:
183:
179:
178:
173:
167:
166:
157:
151:
150:
129:
123:
122:
117:
111:
110:
105:
101:
100:
95:
91:
90:
73:
69:
68:
55:
51:
50:
47:
9:
6:
4:
3:
2:
384:
373:
370:
368:
365:
363:
360:
359:
357:
346:
344:0-7216-2921-0
340:
336:
331:
327:
325:1-4160-2999-0
321:
317:
312:
311:
303:
300:
298:
295:
293:
290:
288:
285:
283:
280:
278:
275:
273:
270:
268:
265:
263:
260:
258:
255:
253:
250:
248:
245:
243:
240:
238:
235:
234:
224:
221:
218:
217:
214:
211:
208:
207:
204:
201:
199:(Natal teeth)
198:
195:
194:
191:
187:
184:
181:
180:
177:
174:
172:
169:
168:
165:
161:
158:
156:
155:Erythrodontia
153:
152:
149:
145:
141:
137:
133:
130:
128:
125:
124:
121:
118:
116:
113:
112:
109:
106:
103:
102:
99:
96:
93:
92:
89:
85:
81:
77:
74:
71:
70:
67:
63:
59:
56:
53:
52:
49:Condition(s)
48:
45:
44:
38:
36:
29:
25:
21:
16:
334:
315:
148:AEC syndrome
144:EEC syndrome
72:Pitted teeth
54:Pegged teeth
32:
20:dynamic list
15:
316:Dermatology
46:Abnormality
356:Categories
308:References
127:Hypodontia
18:This is a
231:See also
176:Bulimia
341:
322:
35:teeth
26:with
339:ISBN
320:ISBN
358::
37:.
347:.
328:.
30:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.